Drug Research, Drug Trials and Therapies

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Drug Research

Drug Trials

Therapies

An Evolving Regulatory Environment for Rare and Orphan Diseases

Advarra

AUGUST 16, 2022

The law established the Office of Orphan Products Development , providing financial incentives for pharmaceutical companies to develop orphan drugs and making it more viable to invest in orphan drug research and development. The impact was clear: Between 1983 and 2020, FDA approved 599 orphan drugs. A Lasting Impact.

Disease

Disease Clinical Trials FDA Approval FDA

Deliberate Dysentery

Codon

JANUARY 21, 2024

We wouldn't do a challenge trial for Ebola, because the disease is extremely severe, and there are currently no licensed treatments or vaccines. You can do a challenge trial with deadly diseases, but you need a “rescue therapy.” There have been deaths in phase 1 medical and drug research among healthy participants.

Vaccine

Vaccine Trials Disease Virus

Drug Discovery Digest

An Evolving Regulatory Environment for Rare and Orphan Diseases

Deliberate Dysentery

Stay Connected